Update on US FDA Inspection at Alkem’s Bioeguivalence Facility
The US FDA had conducted an inspection at the Alkem Laboratories’ Bioequivalence facility located at Taloja, Maharashtra from 8th November, 2018 to 14th November, 2018. At the end of the inspection, no Form 483 was issued. – Medical Buyer Bureau